What's New in the World of Antibiotic Stewardship? Part One
Expires June 30, 2025
This course will provide an overview of the new HEDIS antibiotic measure and highlight its use in the field.
About this On Demand Training
What's New in the World of Antibiotic Stewardship? Part One: Using Performance Measures in Practice to Drive Change
For HEDIS Measurement Year 2022, NCQA released the Antibiotic Utilization for Respiratory Conditions measure. The measure can help health plans more closely monitor antibiotic use and assist with stewardship efforts. It tracks antibiotic prescriptions across both appropriate and inappropriate respiratory conditions. Tracking antibiotic prescribing for all respiratory conditions will provide context about a health plan’s overall antibiotic use when viewed with three HEDIS measures of appropriate testing and inappropriate prescribing.
Dr. Eddie Stenehjem, Senior Medical Director of Medical Specialties and past Medical Director of Antimicrobial Stewardship at Intermountain Healthcare, will join NCQA to describe Intermountain’s ambulatory antibiotic stewardship platform and how Intermountain monitors antibiotic utilization to support antibiotic stewardship efforts.
The purpose of this session is to provide an overview of the new HEDIS antibiotic measure and highlight its use in the field. Participants will be able to ask questions of researchers to learn directly from them about their work.
What You Will Learn
Review the new HEDIS antibiotic measure: Antibiotic Utilization for Respiratory Conditions.
Review the use of antibiotic measures in practice.
Discuss researcher/expert studies and results regarding antibiotic stewardship.
Who Should Attend
Health care professionals
Health care decision makers
Health centers/health practices
Population health organizations
Federal and state government agencies
Sepheen Byron, DRPH, MHS
Sepheen Byron is Assistant Vice President, Performance Measurement, at the National Committee for Quality Assurance (NCQA). She oversees measure development and use of HEDIS and other national evaluation programs and has developed measures used by NCQA for Accreditation, benchmarking and ratings. She also led measure development for Medicaid and CHIP enrollees as part of NCQA’s AHRQ-CMS Pediatric Quality Measures Program Center of Excellence. Ms. Byron is the subject matter expert for measures in the area of antibiotic stewardship, and recently led a project to broaden HEDIS antibiotic measures to additional populations.
Prior to NCQA, Ms. Byron was an Analyst in the Center for Outcomes and Evidence at the Agency for Healthcare Research and Quality, where she assessed the effectiveness of health services.
Ms. Byron has a BA from the University of Virginia, an MHS from the Johns Hopkins University Bloomberg School of Public Health, and a DrPH from the Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
Eddie Stenehjem, MD, MSc
Dr. Edward (Eddie) Stenehjem is an Infectious Diseases physician and Intermountain Healthcare’s Senior Medical Director of Medical Specialties, leading 11 medical specialties for the enterprise in best practice implementation and operations. Dr. Stenehjem served as Intermountain’s first Medical Director of Antimicrobial Stewardship from 2018 through April 2021. During that time, he led antimicrobial stewardship programs across 23 hospitals and over 185 outpatient clinics throughout Utah and Idaho. His research is focused on improving the quality of care delivered to patients with an emphasis on developing, implementing, measuring, and communicating methods of improvement across the continuum of care. More recently, Dr. Stenehjem has been deeply engaged in Intermountain’s COVID response and community advocacy along with vaccine effectiveness research. Dr. Stenehjem has served on multiple national committees and has represented Intermountain Healthcare at the United Nations, the CDC, and the White House.
In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™.
This educational activity is approved for 1.0 nursing contact hours.*
The assigned universal program number:JA0004597-0000-22-031-H04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.
This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.
Disclosure of Relevant Financial Relationships
* Please note – You must attend the entire program to be eligible for total number of contact hours.
Here is the course outline:
The following certificates are awarded when the course is completed:
CCE Other Certificate|
Certificate of Attendance|